Titlebook: Hematopoietic Growth Factors in Oncology; Gary H. Lyman,David C. Dale Book 2011 Springer Science+Business Media, LLC 2011 Biology.Molecula

inhumane

Spongy-Bone

pacifist

Alan E. Lichtins to the determination of the human excretion profile of drugs, the stability of drugs in wastewater, the dynamics of the population, sewage epidemiology provides several opportunities, including a cost-effective, comprehensive, noninvasive, and nearly real-time measure of trends of drug use over time.

Fortuitous

MARS

jaundiced

漂亮才会豪华

Early-Acting Hematopoietic Growth Factors: Biology and Clinical Experiencem for manipulating other stem cell based tissues. This chapter reviews the preclinical knowledge accumulated over ∼40 years, since the discovery of the first such growth factor, and the clinical applications of those that, upon testing in humans, ultimately gained regulatory approval for the treatment of various hematological diseases.

言行自由

Meta-Analysis of Randomized Controlled Trials of Granulocyte Colony-Stimulating Factor Prophylaxis igroups was observed despite the allowed use of secondary G-CSF prophylaxis after an initial occurrence of FN in the control group (. < 0.001). Several additional clinical trials of prophylactic G-CSF in patients with various malignancies receiving different treatment regimens have been reported [6–11].

千篇一律

Granulocyte Colony-Stimulating Factors and Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrond children consistently demonstrating the impact of these agents on neutropenia and its complications [3–5]. Clinical practice guidelines have been put forward by the American Society of Clinical Oncology and other professional organizations for the use of these agents [6–8].